Kovitz Investment Group Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Buy |
+9,102
| New | +$251K | ﹤0.01% | 1195 |
|
|
2025
Q1 | – | Sell |
-7,861
| Closed | -$327K | – | 1276 |
|
|
2024
Q4 | $327K | Sell |
7,861
-40,902
| -84% | -$1.7M | ﹤0.01% | 1011 |
|
|
2024
Q3 | $3.13M | Buy |
48,763
+1,684
| +4% | +$108K | 0.02% | 417 |
|
|
2024
Q2 | $5.59M | Buy |
47,079
+11,510
| +32% | +$1.37M | 0.05% | 268 |
|
|
2024
Q1 | $3.79M | Buy |
35,569
+1,130
| +3% | +$120K | 0.05% | 233 |
|
|
2023
Q4 | $3.42M | Sell |
34,439
-3,605
| -9% | -$359K | 0.06% | 196 |
|
|
2023
Q3 | $3.93M | Sell |
38,044
-1,627
| -4% | -$168K | 0.07% | 175 |
|
|
2023
Q2 | $4.82M | Sell |
39,671
-2,029
| -5% | -$247K | 0.07% | 159 |
|
|
2023
Q1 | $6.4M | Buy |
41,700
+454
| +1% | +$69.7K | 0.11% | 117 |
|
|
2022
Q4 | $7.41M | Buy |
41,246
+937
| +2% | +$168K | 0.15% | 96 |
|
|
2022
Q3 | $4.77M | Buy |
40,309
+76
| +0.2% | +$8.99K | 0.11% | 146 |
|
|
2022
Q2 | $5.75M | Buy |
40,233
+912
| +2% | +$130K | 0.13% | 125 |
|
|
2022
Q1 | $6.77M | Buy |
+39,321
| New | +$6.77M | 0.13% | 118 |
|
|
2021
Q3 | – | Sell |
-1,057
| Closed | -$248K | – | 427 |
|
|
2021
Q2 | $248K | Buy |
+1,057
| New | +$248K | ﹤0.01% | 381 |
|